Novo Nordisk A/S annual net income for fiscal TTM was DKK 116.4 billion, an increase of 13.7% from DKK 102.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | DKK 116.4B | DKK 102.4B | DKK 101.0B | DKK 83.7B | DKK 55.5B | DKK 47.8B | DKK 42.1B | DKK 39.0B | DKK 38.6B | DKK 38.1B | DKK 37.9B | DKK 34.9B | DKK 26.5B | DKK 25.2B | DKK 21.4B | DKK 17.1B | DKK 14.4B | DKK 10.8B | DKK 9.7B | DKK 8.5B | DKK 6.5B |
DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | DKK 21.0B | DKK 48.6B | DKK 26.9B | DKK 20.0B | DKK 26.5B | DKK 29.0B | DKK 28.2B | DKK 27.3B | DKK 20.1B |
DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NVO metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All NVO financial statements → Interactive NVO charts →
About TickerBase · Data methodology & sources · Privacy · Terms